MYOS RENS Technology is Biotechnology in United States that focus on Rens Technology Inc business. They cover business area such as Myos Rens Technology Inc, development, commercialization, product, muscle health, sarcopenia, cachexia, degenerative muscle disease, performance, muscle tissue, its research, develop strategy, therapeutic intervention, muscle relate condition, Sarcopenia, Cachexia.
-
Rens Technology Inc
-
Morris Technical Center, 45 Horsehill Road
Suite 106
Cedar Knolls, NJ 07927
United States
Private
Myos Rens Technology Incdevelopmentcommercializationproductmuscle healthsarcopeniacachexiadegenerative muscle diseaseperformancemuscle tissueits researchdevelop strategytherapeutic interventionmuscle relate conditionSarcopeniaCachexia
* We use standard office opening hours in near MYOS RENS Technology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MYOS RENS Technology is Biotechnology business from United States that founded in - ( years old in ), MYOS RENS Technology business is focusing on Rens Technology Inc.
MYOS RENS Technology headquarter office and corporate office address is located in Morris Technical Center, 45 Horsehill Road Suite 106 Cedar Knolls, NJ 07927 United States.
MYOS RENS Technology was founded in United States.
In , MYOS RENS Technology is currently focus on Rens Technology Inc sector.
Above is snippet of Google Trends for "Rens Technology Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MYOS RENS Technology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
